MACQUARIE GROUP LTD - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$18,000
-41.9%
28,0770.0%0.00%
Q4 2021$31,000
-39.2%
28,0770.0%0.00%
Q3 2021$51,000
+218.8%
28,077
+350.8%
0.00%
Q2 2021$16,000
-27.3%
6,2280.0%0.00%
Q1 2021$22,000
+4.8%
6,228
-23.5%
0.00%
Q4 2020$21,0000.0%8,1380.0%0.00%
Q3 2020$21,000
-22.2%
8,1380.0%0.00%
Q2 2020$27,0008,1380.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders